Strides Pharma NCLT Approves Arco Lab Demerger

NCLT Bengaluru approved the demerger of Arco Lab's Life Sciences and Digital Innovation businesses into Pivot Path on May 18, 2026.
The scheme, effective from Appointed Date April 10, 2025, will make Pivot Path a wholly-owned Strides subsidiary.
Arco Lab and Pivot Path are obtaining the certified NCLT order to file with the Registrar of Companies for scheme effectiveness.